StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.73−0.05 (-2.81%)

Close on Nov 18, 2026Market cap $52.74MP/E –Yield –

XBiotech shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

XBiotech's shares outstanding was 30M at Jun 30, 2026. For fiscal 2025 it was 30M, up 0.1% from the year before. Over ten years it grew -0.1% a year on average. The highest annual figure on record is 46M in fiscal 2019.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202530M+0.1%
FY2024Dec 31, 202430M+0.1%
FY2023Dec 31, 202330M-0.0%
FY2022Dec 31, 202230M+1.3%
FY2021Dec 31, 202130M-2.5%
FY2020Dec 31, 202031M-33.5%
FY2019Dec 31, 201946M+29.4%
FY2018Dec 31, 201836M+2.7%
FY2017Dec 31, 201735M+7.6%
FY2016Dec 31, 201632M+5.2%
FY2015Dec 31, 201531M+27.5%
FY2014Dec 31, 201424M+8.7%
FY2013Dec 31, 201322M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202630M0.0%
Q1 FY2026Mar 31, 202630M0.0%
Q4 FY2025Dec 31, 202530M+0.1%
Q3 FY2025Sep 30, 202530M+0.0%
Q2 FY2025Jun 30, 202530M+0.1%
Q1 FY2025Mar 31, 202530M+0.1%
Q4 FY2024Dec 31, 202430M+0.1%
Q3 FY2024Sep 30, 202430M+0.1%
Q2 FY2024Jun 30, 202430M+0.1%
Q1 FY2024Mar 31, 202430M+0.0%
Q4 FY2023Dec 31, 202330M+0.0%
Q3 FY2023Sep 30, 202330M-0.0%
Q2 FY2023Jun 30, 202330M-0.0%
Q1 FY2023Mar 31, 202330M0.0%
Q4 FY2022Dec 31, 202230M+0.1%
Q3 FY2022Sep 30, 202230M+0.3%
Q2 FY2022Jun 30, 202230M+1.5%
Q1 FY2022Mar 31, 202230M+3.5%
Q4 FY2021Dec 31, 202130M+3.9%
Q3 FY2021Sep 30, 202130M+4.5%
Q2 FY2021Jun 30, 202130M+3.9%
Q1 FY2021Mar 31, 202129M-18.7%
Q4 FY2020Dec 31, 202029M-58.6%
Q3 FY2020Sep 30, 202029M-29.2%
Q2 FY2020Jun 30, 202029M-23.1%
Q1 FY2020Mar 31, 202036M+0.5%
Q4 FY2019Dec 31, 201971M+97.3%
Q3 FY2019Sep 30, 201941M+14.5%
Q2 FY2019Jun 30, 201938M+4.7%
Q1 FY2019Mar 31, 201936M+1.5%
Q4 FY2018Dec 31, 201836M+10.9%
Q3 FY2018Sep 30, 201836M+1.1%
Q2 FY2018Jun 30, 201836M+1.4%
Q1 FY2018Mar 31, 201835M+6.5%
Q4 FY2017Dec 31, 201732M-0.6%
Q3 FY2017Sep 30, 201735M+9.2%
Q2 FY2017Jun 30, 201735M–
Q1 FY2017Mar 31, 201733M–
Q4 FY2016Dec 31, 201633M–
Q3 FY2016Sep 30, 201632M–

More XBiotech figures

See a number that looks wrong?